Remove Disease Remove Marketing Remove Synthetic Chemistry
article thumbnail

Enthera Pharmaceuticals Appoints Kazumi Shiosaki to Its Board of Directors and Lisa Olson to Its Scientific Advisory Board to Push Forward Company Growth and Development

The Pharma Data

Kazumi was also a co-founder and CEO of Mitobridge, a start-up company developing mitochondrial drugs for the treatment of muscle and kidney diseases, until its acquisition by Astellas Pharma in 2018. Kazumi holds a PhD in Synthetic Chemistry from UC Berkeley. 3, 2020 08:00 UTC.

article thumbnail

BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies

The Pharma Data

Utilizing drug delivery platform technologies, BetterLife is refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ProstaStream

The Pharma Data

The Journal of Synthetic Chemistry confirms that broccoli leaf extracts have extremely powerful and valuable nutrients, ones that are required to maintain the good health of the prostate. Frank Neal is a pen name used for marketing purposes and to protect the author’s identity.

article thumbnail

AWS helps Pfizer accelerate drug development and clinical manufacturing

The Pharma Data

. “Pfizer’s goal with AWS is to expedite the processes for drug discovery and development in ways that can ultimately enhance patient experiences and deliver new therapies to market. Pfizer has an extensive collection of documents that contain valuable data from a variety of drug development processes.